Meeting
2017 ASCO Annual Meeting
Multi-gene hereditary cancer testing among men with breast cancer.
Authors
Krystal Brown
Myriad Genetic Laboratories, Inc., Salt Lake City, UT
Krystal Brown , Gregory Sampang Calip , Ryan Bernhisel , Brent Evans , Eric Thomas Rosenthal , Jennifer Saam , Johnathan Lancaster , Kent Hoskins
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Cancer Prevention, Genetics, and Epidemiology
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Cancer Genetics
Citation
J Clin Oncol 35, 2017 (suppl; abstr 1532)
DOI
10.1200/JCO.2017.35.15_suppl.1532
Abstract #
1532
Poster Bd #
190
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
Safety of multiplex gene testing for inherited cancer risk in a fully accrued prospective trial.
First Author: Allison W. Kurian
Poster
2017 ASCO Annual Meeting
Expanded yield of multiplex panel testing in fully accrued prospective trial.
First Author: Gregory Idos
Poster
2017 ASCO Annual Meeting
Performance of mutation risk prediction models in a racially diverse multi-gene panel testing cohort.
First Author: Gregory Idos
Poster
2019 ASCO Annual Meeting
Prevalence and penetrance of breast cancer-associated mutations identified by multiple-gene sequencing in the Women’s Health Initiative.
First Author: Allison W. Kurian